We studied the expression of C9orf72 gene in pathologies associated with hexanucleotide repeats expansion in this gene: frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). The study included 7 patients with hexanucleotide repeats expansion in the C9orf72 gene and 9 patients of the control group. The expression of C9orf72 mRNA was evaluated in blood leukocytes by real-time PCR. Methylation of CpG-sites in C9orf72 promotor region was evaluated by DNA sequencing after bisulfite conversion. A 2-fold decrease in the C9orf72 gene expression was found in patients with hexanucleotide repeats expansion in comparison with controls, though the difference did not reach statistical significance due to small sample size. The highest expression was shown for ALS in comparison with FTD and FTD-ALS phenotype. A trend to inverse correlation between C9orf72 mRNA level and promoter methylation of this gene as well as between mRNA level and age of disease onset was demonstrated.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abramycheva NYu, Lysogorskaya EV, Shpilyukova YuA, Vetchinova AS, Zakharova MN, Illarioshkin SN. Molecular structure of amyotrophic lateral sclerosis in Russian population. Nervo-Myshechnue Bol. 2016;6(4):21-27. Russian.
Shpilyukova YuA, Fedotova EYu, Pogoda TV, Abramycheva NYu, Vetchinova AS, Zakharova MN, Illarioshkin SN. Evaluation of methylation status of the 5’-promoter region of C9orf72 gene in Russian patients with neurodegenerative diseases. Nervo-Myshechnue Bol. 2018;8(2):33-41.
Abramycheva NY, Lysogorskaia EV, Stepanova MS, Zakharova MN, Kovrazhkina EA, Razinskaya OD, Smirnov AP, Maltsev AV, Ustyugov AA, Kukharsky MS, Khritankova IV, Bachurin SO, Cooper-Knock J, Buchman VL, Illarioshkin SN, Skvortsova VI, Ninkina N. C9ORF72 hexanucleotide repeat expansion in ALS patients from the Central European Russia population. Neurobiol. Aging. 2015;36(10):2908.e5-9. doi: https://doi.org/10.1016/j.neurobiolaging.2015.07.004
Bauer PO. Methylation of C9orf72 expansion reduces RNA foci formation and dipeptide-repeat proteins expression in cells. Neurosci Lett. 2016;612:204-209. doi: https://doi.org/10.1016/j.neulet.2015.12.018
Belzil VV, Bauer PO, Prudencio M, Gendron TF, Stetler CT, Yan IK, Pregent L, Daughrity L, Baker MC, Rademakers R, Boylan K, Patel TC, Dickson DW, Petrucelli L. Reduced C9orf72 gene expression in c9FTD/ALS is caused by histone trimethylation, an epigenetic event detectable in blood. Acta Neuropathol. 2013;126(6):895-905. doi: https://doi.org/10.1007/s00401-013-1199-1
DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, Nicholson AM, Finch NA, Flynn H, Adamson J, Kouri N, Wojtas A, Sengdy P, Hsiung GY, Karydas A, Seeley WW, Josephs KA, Coppola G, Geschwind DH, Wszolek ZK, Feldman H, Knopman DS, Petersen RC, Miller BL, Dickson DW, Boylan KB, Graff-Radford NR, Rademakers R. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72(2):245-256. doi: https://doi.org/10.1016/j.neuron.2011.09.011
Gijselinck I, Van Mossevelde S, van der Zee J, Sieben A, Engelborghs S, De Bleecker J, Ivanoiu A, Deryck O, Edbauer D, Zhang M, Heeman B, Bäumer V, Van den Broeck M, Mattheijssens M, Peeters K, Rogaeva E, De Jonghe P, Cras P, Martin JJ, de Deyn PP, Cruts M, Van Broeckhoven C. The C9orf72 repeat size correlates with onset age of disease, DNA methylation and transcriptional downregulation of the promoter. Mol. Psychiatry. 2016;21(8):1112-1124. doi: https://doi.org/10.1038/mp.2015.159
Haeusler AR, Donnelly CJ, Periz G, Simko EA, Shaw PG, Kim MS, Maragakis NJ, Troncoso JC, Pandey A, Sattler R, Rothstein JD, Wang J. C9orf72 nucleotide repeat structures initiate molecular cascades of disease. Nature. 2014;507:195-200. doi: https://doi.org/10.1038/nature13124
Mizielinska S, Isaacs AM. C9orf72 amyotrophic lateral sclerosis and frontotemporal dementia: gain or loss of function?. Curr. Opin. Neurol. 2014;27(5):515-523. doi: https://doi.org/10.1097/WCO.0000000000000130
Ng AS, Rademakers R, Miller BL. Frontotemporal dementia: a bridge between dementia and neuromuscular disease. Ann. NY Acad. Sci. 2015;1338):71-93. doi: https://doi.org/10.1111/nyas.12638
Wen X, Tan W, Westergard T, Krishnamurthy K, Markandaiah SS, Shi Y, Lin S, Shneider NA, Monaghan J, Pandey UB, Pasinelli P, Ichida JK, Trotti D. Antisense proline-arginine RAN dipeptides linked to C9ORF72-ALS/FTD form toxic nuclear aggregates that initiate in vitro and in vivo neuronal death. Neuron. 2014;84(6):1213-1225. doi: https://doi.org/10.1016/j.neuron.2014.12.010
Xi Z, van Blitterswijk M, Zhang M, McGoldrick P, McLean JR, Yunusova Y, Knock E, Moreno D, Sato C, McKeever PM, Schneider R, Keith J, Petrescu N, Fraser P, Tartaglia MC, Baker MC, Graff-Radford NR, Boylan KB, Dickson DW, Mackenzie IR, Rademakers R, Robertson J, Zinman L, Rogaeva E. Jump from pre-mutation to pathologic expansion in C9orf72. Am. J. Hum. Genet. 2015;96(6):962-970. doi: https://doi.org/10.1016/j.ajhg.2015.04.016
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 169, No. 5, pp. 604-607, May, 2020
Rights and permissions
About this article
Cite this article
Shpilyukova, Y.A., Fedotova, E.Y., Abramycheva, N.Y. et al. C9orf72 Gene Expression in Frontotemporal Dementia and Amyotrophic Lateral Sclerosis. Bull Exp Biol Med 169, 673–676 (2020). https://doi.org/10.1007/s10517-020-04952-0
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-020-04952-0